|
|
Multiple Sclerosis
- The World of Multiple Sclerosis
- Int'l Fed. of Multiple Sclerosis Societies (UK)
- The Myelin Project - Washington
DC (US)
- Nat'l Multiple Sclerosis
Society (US)
- Review Multiple
Sclerosis - NeuroWeb Forum, Mass. Gen. Hosp (US)
- MEDLINE
- Interferon
beta-1b is effective in relapsing-remitting multiple sclerosis. II.
MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled
trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study
Group. Neurology 1993 Apr;43(4):662-7
- Placebo-controlled
multicentre randomised trial of interferon beta-1b in treatment of
secondary progressive multiple sclerosis. European Study Group
on interferon beta-1b in secondary progressive MS. Lancet 1998 Nov
7;352(9139):1491-7
- Randomised
double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting
multiple sclerosis. PRISMS (Prevention of Relapses and Disability
by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study
Group. Lancet 1998 Nov 7;352(9139):1498-504
- Association
of human herpes virus 6 (HHV-6) with multiple sclerosis:increased
IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.
Nat Med 1997 Dec;3(12):1394-7. Soldan SS, Berti R, Salem N,
Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland
HF, Lin HC, Patnaik M, Jacobson S. Viral Immunology Section, National
Institute of Neurological Disorders and Stroke, Bethesda, Maryland
20892, USA
|
